\-\ Texto\\:\\ \ \(0\)\
\-\ 1\\.\\ bilaterally\\ palpable\\ flank\\ masses\ \(0\)\
\-\ 2\\.\\ hypertension\ \(0\)\
\-\ 3\\.\\ elevated\\ bun\\ and\\ creatinine\ \(0\)\
\-\ patients\\ with\\ adpckd\\ need\\ close\\ followup\\ for\\ treatment\\ of\\ hypertension\\ and\\ continual\\ assessement\\ of\\ renal\\ function\\.\\ \\ symptoms\\ of\\ urinary\\ tract\\ infection\\ \\(which\\ are\\ common\\ in\\ patients\\ with\\ adpckd\\)\\ should\\ be\\ treated\\ promptly\\ with\\ appropriate\\ antibiotics\\ to\\ preserve\\ as\\ much\\ renal\\ function\\ as\\ possible\\.\ \(0\)\
\-\ genotyping\\,\\ genetic\\ testing\\ of\\ relatives\\,\\ and\\ fetal\\ ultrasound\\ can\\ help\\ predict\\ or\\ rule\\ out\\ the\\ disease\\ in\\ ohter\\ family\\ members\\.\ \(0\)\
\-\ preevaluation\\ for\\ renal\\ transplantation\\ before\\ it\\ becomes\\ necessary\\.\ \(0\)\
\-\ symptomatic\\ cysts\\ can\\ be\\ treated\\ surgically\\ or\\ with\\ a\\ combination\\ of\\ percutaneous\\ drainage\\ and\\ dehydrated\\ etoh\\ ablation\\ therapy\\.\ \(0\)\
\-\ multiple\\ hyoechoic\\ cysts\\ of\\ many\\ different\\ sizes\\ are\\ seen\\ in\\ both\\ the\\ renal\\ and\\ hepatic\\ parenchyma\\.\ \(0\)\
\-\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\ \(5\)\
\-\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\ \(5\)\
\-\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\\ \ \(0\)\
\-\ multilocular\\ cystic\\ nephroma\\ \ \(0\)\
\-\ tuberous\\ sclerosis\\ \ \(16\)\
\-\ von\\ hippel\\-lindau\\ syndrome\ \(0\)\
\-\ 42\\ year\\ old\\ female\\ with\\ end\\-stage\\ renal\\ disease\\.\ \(1\)\
\-\ this\\ patient\\ was\\ already\\ in\\ end\\-stage\\ renal\\ failure\\ and\\ reported\\ having\\ multiple\\ episodes\\ of\\ pyelonephritis\\ in\\ the\\ past\\ 10\\ years\\.\\ she\\ is\\ currently\\ on\\ a\\ waiting\\ list\\ for\\ a\\ kidney\\ transplant\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adpckd\\:\\ 0\\.08460803378548493\ \(0\)\
\-\ renal\\:\\ 0\\.08023361092056466\ \(0\)\
\-\ polycystic\\:\\ 0\\.07897372356676462\ \(0\)\
\-\ autosomal\\:\\ 0\\.07725495957904074\ \(0\)\
\-\ end\\-stage\\:\\ 0\\.06361946065483633\ \(0\)\
\-\ kidney\\:\\ 0\\.06271632198020853\ \(0\)\
\-\ assessement\\:\\ 0\\.04591415845815884\ \(0\)\
\-\ genotyping\\:\\ 0\\.04591415845815884\ \(0\)\
\-\ preevaluation\\:\\ 0\\.04591415845815884\ \(0\)\
\-\ hyoechoic\\:\\ 0\\.04591415845815884\ \(0\)\
\-\ dominant\\:\\ 0\\.04542886591367698\ \(0\)\
\-\ ohter\\:\\ 0\\.04230401689274246\ \(0\)\
\-\ continual\\:\\ 0\\.03869387532732608\ \(0\)\
\-\ function\\:\\ 0\\.03773501638621133\ \(0\)\
\-\ relatives\\:\\ 0\\.0375316693308979\ \(0\)\
\-\ disease\\:\\ 0\\.03637337346915896\ \(0\)\
\-\ hypertension\\:\\ 0\\.03509146929479362\ \(0\)\
\-\ cysts\\:\\ 0\\.03486935711282674\ \(0\)\
\-\ preserve\\:\\ 0\\.03447028045119936\ \(0\)\
\-\ predict\\:\\ 0\\.03447028045119936\ \(0\)\
\-\ dehydrated\\:\\ 0\\.03447028045119936\ \(0\)\
\-\ nephroma\\:\\ 0\\.03297193632384634\ \(0\)\
\-\ promptly\\:\\ 0\\.03255504722138\ \(0\)\
\-\ waiting\\:\\ 0\\.03255504722138\ \(0\)\
\-\ members\\:\\ 0\\.031473592196493316\ \(0\)\
\-\ multilocular\\:\\ 0\\.031473592196493316\ \(0\)\
\-\ hippel\\-lindau\\:\\ 0\\.03031138620006514\ \(0\)\
\-\ transplantation\\:\\ 0\\.02958345941686119\ \(0\)\
\-\ recessive\\:\\ 0\\.02958345941686119\ \(0\)\
\-\ etoh\\:\\ 0\\.029149180203636965\ \(0\)\
\-\ sizes\\:\\ 0\\.029149180203636965\ \(0\)\
\-\ von\\:\\ 0\\.028028808434798706\ \(0\)\
\-\ ablation\\:\\ 0\\.02786345063107693\ \(0\)\
\-\ list\\:\\ 0\\.02786345063107693\ \(0\)\
\-\ treated\\:\\ 0\\.0266442795425402\ \(0\)\
\-\ already\\:\\ 0\\.026447129196266298\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.025973317851444806\ \(0\)\
\-\ creatinine\\:\\ 0\\.02533476409054724\ \(0\)\
\-\ bun\\:\\ 0\\.024589447196585405\ \(0\)\
\-\ transplant\\:\\ 0\\.024589447196585405\ \(0\)\
\-\ tuberous\\:\\ 0\\.02450335708225618\ \(0\)\
\-\ genetic\\:\\ 0\\.024335331758202947\ \(0\)\
\-\ percutaneous\\:\\ 0\\.023568015535510974\ \(0\)\
\-\ becomes\\:\\ 0\\.02329017188600424\ \(0\)\
\-\ patients\\:\\ 0\\.023037235410062768\ \(0\)\
\-\ fetal\\:\\ 0\\.02265422034016622\ \(0\)\
\-\ surgically\\:\\ 0\\.022535844032470616\ \(0\)\
\-\ 42\\:\\ 0\\.022535844032470616\ \(0\)\
\-\ combination\\:\\ 0\\.022420098528383586\ \(0\)\
\-\ need\\:\\ 0\\.02219604964773936\ \(0\)\
\-\ help\\:\\ 0\\.02219604964773936\ \(0\)\
\-\ different\\:\\ 0\\.022034119506749612\ \(0\)\
\-\ episodes\\:\\ 0\\.02198124257204119\ \(0\)\
\-\ close\\:\\ 0\\.02172462252513086\ \(0\)\
\-\ testing\\:\\ 0\\.021528058316886867\ \(0\)\
\-\ followup\\:\\ 0\\.021246458206104178\ \(0\)\
\-\ appropriate\\:\\ 0\\.020979305631169023\ \(0\)\
\-\ flank\\:\\ 0\\.020936082699842484\ \(0\)\
\-\ urinary\\:\\ 0\\.020602635518775135\ \(0\)\
\-\ much\\:\\ 0\\.020602635518775135\ \(0\)\
\-\ having\\:\\ 0\\.020443590082003877\ \(0\)\
\-\ can\\:\\ 0\\.020189816171552806\ \(0\)\
\-\ tract\\:\\ 0\\.019713960950906575\ \(0\)\
\-\ necessary\\:\\ 0\\.019713960950906575\ \(0\)\
\-\ parenchyma\\:\\ 0\\.01895504526767015\ \(0\)\
\-\ before\\:\\ 0\\.018838653086982668\ \(0\)\
\-\ multiple\\:\\ 0\\.01874797920290905\ \(0\)\
\-\ drainage\\:\\ 0\\.018613392754723207\ \(0\)\
\-\ rule\\:\\ 0\\.01858590808232298\ \(0\)\
\-\ hepatic\\:\\ 0\\.01858590808232298\ \(0\)\
\-\ many\\:\\ 0\\.01829277872868449\ \(0\)\
\-\ family\\:\\ 0\\.018241210650649535\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01768220533694902\ \(0\)\
\-\ currently\\:\\ 0\\.017636316640687797\ \(0\)\
\-\ failure\\:\\ 0\\.01743467855641337\ \(0\)\
\-\ antibiotics\\:\\ 0\\.016717272696200526\ \(0\)\
\-\ reported\\:\\ 0\\.01622434818008235\ \(0\)\
\-\ sclerosis\\:\\ 0\\.015986016840762212\ \(0\)\
\-\ palpable\\:\\ 0\\.01577406793020724\ \(0\)\
\-\ 3\\.\\:\\ 0\\.015228511521566287\ \(0\)\
\-\ elevated\\:\\ 0\\.015100606048745118\ \(0\)\
\-\ masses\\:\\ 0\\.015044752072896288\ \(0\)\
\-\ 10\\:\\ 0\\.015003251189306824\ \(0\)\
\-\ possible\\:\\ 0\\.01498949072335454\ \(0\)\
\-\ out\\:\\ 0\\.014708613941971437\ \(0\)\
\-\ bilaterally\\:\\ 0\\.01461825645064533\ \(0\)\
\-\ should\\:\\ 0\\.014188586155670833\ \(0\)\
\-\ 2\\.\\:\\ 0\\.014153354905209678\ \(0\)\
\-\ past\\:\\ 0\\.014141663916387676\ \(0\)\
\-\ 1\\.\\:\\ 0\\.013902026907800003\ \(0\)\
\-\ be\\:\\ 0\\.013726632534832594\ \(0\)\
\-\ as\\:\\ 0\\.013464349019730497\ \(0\)\
\-\ ultrasound\\:\\ 0\\.013203763463574495\ \(0\)\
\-\ years\\:\\ 0\\.013068974671971262\ \(0\)\
\-\ infection\\:\\ 0\\.01293758632329587\ \(0\)\
\-\ cystic\\:\\ 0\\.012836628683602908\ \(0\)\
\-\ syndrome\\:\\ 0\\.012728680087159591\ \(0\)\
\-\ she\\:\\ 0\\.012493677820073813\ \(0\)\
\-\ are\\:\\ 0\\.012134102838850018\ \(0\)\
\-\ therapy\\:\\ 0\\.011899170813753192\ \(0\)\
\-\ common\\:\\ 0\\.011647225062272901\ \(0\)\
\-\ for\\:\\ 0\\.011392314822542424\ \(0\)\
\-\ both\\:\\ 0\\.011365624951490214\ \(0\)\
\-\ symptoms\\:\\ 0\\.01109196602551114\ \(0\)\
\-\ in\\:\\ 0\\.010973886201569139\ \(0\)\
\-\ or\\:\\ 0\\.010432528635038619\ \(0\)\
\-\ it\\:\\ 0\\.010004418669442794\ \(0\)\
\-\ female\\:\\ 0\\.009149793080457467\ \(0\)\
\-\ treatment\\:\\ 0\\.009008421664587953\ \(0\)\
\-\ seen\\:\\ 0\\.00879493549514422\ \(0\)\
\-\ which\\:\\ 0\\.008308044725221607\ \(0\)\
\-\ a\\:\\ 0\\.006196871903415645\ \(0\)\
\-\ and\\:\\ 0\\.005625281429131827\ \(0\)\
\-\ was\\:\\ 0\\.005147278761529619\ \(0\)\
\-\ this\\:\\ 0\\.005005922986011109\ \(0\)\
\-\ year\\:\\ 0\\.004979714944129764\ \(0\)\
\-\ old\\:\\ 0\\.004556951025324243\ \(0\)\
\-\ patient\\:\\ 0\\.004461416306856187\ \(0\)\
\-\ of\\:\\ 0\\.004247534404093328\ \(0\)\
\-\ on\\:\\ 0\\.003770265689403271\ \(0\)\
\-\ \\(\\:\\ 0\\.0037623006575201066\ \(0\)\
\-\ \\)\\:\\ 0\\.0037163421464234637\ \(0\)\
\-\ with\\:\\ 0\\.0030469837523408785\ \(0\)\
\-\ is\\:\\ 0\\.0029285978040871127\ \(0\)\
\-\ \\,\\:\\ 0\\.0028198965158050767\ \(0\)\
\-\ to\\:\\ 0\\.00222431306480722\ \(0\)\
\-\ the\\:\\ 0\\.002160145073494153\ \(0\)\
\-\ \\.\\:\\ 0\\.0016640407545631068\ \(0\)\
